Probiotics may reduce risk of gestational diabetes

April 4, 2017
Probiotics may reduce risk of gestational diabetes
Credit: University of Otago

Research led by the University of Otago, Wellington has found that a 'home-grown' naturally occurring probiotic reduces the risk of developing diabetes during pregnancy (gestational diabetes) and lowers fasting blood sugar.

The joint study by University of Otago, Wellington, and University of Auckland researchers, funded by the Health Research Council of New Zealand, was published this week in the British Journal of Nutrition.

The probiotic (Lactobacillus rhamnosus HN001), produced by Fonterra, which is used to make fermented milk products such as yoghurt, was given in capsule form to 194 women from early pregnancy, while 200 women received a placebo. Gestational was assessed at 24-30 weeks gestation.

"Using the current New Zealand definition for , 6.5 per cent of the women had diabetes in the , versus 2.1 per cent in the probiotic group. This is a 68 per cent reduction," says study leader Professor Julian Crane from the University of Otago, Wellington.

"We found that the protective effects were stronger among older women and were stronger among women who had previously had gestational diabetes," Professor Crane says.

Fasting blood glucose was also significantly lower among taking the probiotic compared to placebo.

"This is an exciting result suggesting that this probiotic may be interacting with the normal gut bacteria in some way to reduce glucose levels in pregnancy," he says.

The researchers have previously shown that this same probiotic has effects on the immune system and reduces eczema by 50 per cent in infancy.

Professor Crane says that the next steps will be to investigate whether this probiotic can reduce the now increasingly common risk in the population of developing diabetes.

"We have recently received funding from a partnership fund from the Health Research Council of New Zealand, Ministry of Health and the Healthier Lives National Science Challenge to explore the use of this probiotic combined with a prebiotic to see if we can prevent the progression of pre-diabetes amongst adults at risk," Professor Crane says.

Explore further: Impact of probiotics on metabolic health in women with gestational diabetes

More information: Kristin L. Wickens et al. Early pregnancy probiotic supplementation with Lactobacillus rhamnosus HN001 may reduce the prevalence of gestational diabetes mellitus: a randomised controlled trial, British Journal of Nutrition (2017). DOI: 10.1017/S0007114517000289

Related Stories

Impact of probiotics on metabolic health in women with gestational diabetes

February 2, 2015
In a study to be presented on Feb. 5 in an oral concurrent session at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report on the effect of a probiotic capsule ...

Early periods associated with risk of gestational diabetes

March 6, 2017
The age at which girls start menstruating could flag a later risk of diabetes during pregnancy, according to a University of Queensland study

HbA1c more than 5.9 percent can ID diabetes in early pregnancy

September 16, 2014
(HealthDay)—An HbA1c threshold of ≥5.9 percent can identify all women with gestational diabetes in early pregnancy, according to a study published online Sept. 4 in Diabetes Care.

Fasting and probiotics may help prevent diabetes

May 11, 2016
Very low calorie diets and probiotics may both help prevent Type2 diabetes and a scientific trial to investigate this will be underway in Auckland this year.

Probiotic supplements beneficial in rheumatoid arthritis

May 5, 2016
(HealthDay)—Probiotic supplementation seems beneficial for patients with rheumatoid arthritis (RA), according to a study published online May 2 in the International Journal of Rheumatic Diseases.

Pregnancy-linked diabetes poses risks for mom, baby

February 16, 2017
(HealthDay)—Diabetes that develops during pregnancy—known as gestational diabetes—carries health risks for both the mom-to-be and her baby, new research confirms.

Recommended for you

Pancreatic islets study may spur diabetes treatment advances

September 22, 2017
Investigators in the Vanderbilt Diabetes Research and Training Center (VDRTC) and collaborators at Stanford University have discovered new insights into the molecular mechanisms of cell proliferation in juvenile human pancreatic ...

Finding a natural defense against clogged arteries

September 20, 2017
In type 2 diabetes, chronic inflammation drives cardiovascular disease, the leading cause of death among people with the condition. Researchers at Joslin Diabetes Center now have identified an unexpected natural protective ...

Study identifies blood vessel as a therapeutic target for diabetes

September 14, 2017
Blood vessels have an often overlooked role of regulating the transfer of nutrients from the blood to organs in the body. In a new Yale-led study, researchers have identified a role of a secreted protein, apelin, in regulating ...

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

September 14, 2017
A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes ...

Epigenetic 'fingerprint' identifies diabetes risk

September 14, 2017
Deakin researchers have identified an epigenetic marker that predicts risk of type 2 diabetes in women with gestational diabetes.

Could swine flu be linked to type 1 diabetes?

September 14, 2017
(HealthDay)—Young people who've been infected with the H1N1 swine flu virus may be at increased risk for type 1 diabetes, a new study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.